
The Acute Care™ myoglobin assay is an in vitro diagnostic test for the measurement of myoglobin in heparinized whole blood /plasma. Myoglobin measurements can be used as an aid in diagnosing myocardial infarction.
Following myocadial necrosis associated with myocardial infarction (MI), myoglobin is one of the first markers to rise above normal levels, increasing measurably above baseline within 2-4 hours post-infarct, peaking at 9-12 hours, and returning to baseline within 24-36 hours.1,2 In the absence of skeletal muscle trauma or other factors associated with a non-cardiac related increase in circulating myoglobin, myoglobin levels have been used as an early marker for MI.3,4 A number of reports suggest the measurement of myoglobin as a diagnostic aid in “ruling-out” myocardial infarction with negative predictive values of up to 100% reported at certain time periods after onset of symptoms.
Myoglobin |
|
Assay Range |
1 – 900 ng/mL (µg/L) |
Sensitivity |
1.0 ng/mL |
Reproducibility (CV) |
3.4% at 56 ng/mL |
Calibration Stability |
60 days |
DilPak™ Automatic Dilution |
Yes |
Sodium Heparin Tubes |
Yes |
Lithium Heparin Tubes |
Yes |
Loading...
Women's Health Community Supported by Hologic
Comprehensive information on women’s health issues and management, management and personalisation.
Enterprise Imaging Community
Advanced and scalable radiology solutions that can help improve care coordination, increase speed and facilitate accurate clinical decisions.
Decision Support Community
Leading the way in highlighting useful and efficient decision support tools for improved patient outcomes.
Sepsis Community Supported by Abionic
Addressing the latest developments in sepsis and providing clinically useful information for diagnosis and treatment of patients.
Cero Generation Launches 70MW Agrivoltaic Project in Italy with Support from Philips & HEINEKEN
Cero Generation’s 70MW agrivoltaic solar PV project in Province of Latina... Read more
Agamon Health Partners with Mayo Clinic to Bridge Cardiology Gaps Using AI Know-How
Agamon Health's Patient Adherence platform is aimed at raising standards... Read more
Hologic & Bayer Partner for Global Enhanced Mammography Solutions to Imaging Centers
Partnership Includes Education and Training to Increase Clinician Confidence... Read more
Breast cancer: more cases detected with the help of AI
One radiologist supported by AI detected more cases of breast cancer... Read more
Championing Billions of Women Through the Hologic Global Women’s Health Index
The invitation proved too momentous to pass up. It arrived as... Read more
JOIN OUR MANAGEMENT COMMUNITY
Raymond Benza, Named Chief of Pulmonary Hypertension for the Mount Sinai Health System
Awarded $4 million in NIH grants to study new therapies for improved survival... Read more
MediView Announces New Board Member
MediView is pleased to announce the addition of Karley Yoder as a new... Read more
Dr Gregor Smith: Scotland’s New Interim CMO
Dr Gregor Smith has been appointed Scotland's interim Chief Medical... Read more
NICE Appoints New CEO
The UK’s National Institute for Health and Care Excellence (NICE)... Read more
John Ormiston Awarded the EuroPCR 2017 Ethica Award
The 2017 Ethica Award, the highest honour of the European cardiovascular... Read more
JOIN OUR MANAGEMENT COMMUNITY